10 mm Hg higher PASP was associated with a 3.32-point lower PF score (95% . In a multivariable model that included BIS estimates, both left ventricular posterior wall thickness (LVPW, per 5 mm) and ECW were associated with a higher PASP (LVPW 4.21 mm Hg, 95% 0.38-8.04; ECW 1.12 mm Hg per liter, 95% CI 0.07-2.18). Higher LVPW and ECW were independently associated with a lower PF score. Conclusion: Left ventricular hypertrophy and elevated pulmonary pressure are associated with worse self-reported physical function in patients on hemodialysis. The role of chronic volume overload on PASP and PF score should be evaluated in a prospective manner.
Introduction
The heavy burden of cardiovascular disease among patients with ESRD has long been appreciated [1] , but there is an increasing recognition of the potential contribution of the uremic milieu to heart disease by various mechanisms, including myocardial wall stress from hypertension and volume overload, subclinical ischemia, cardiac remodeling, and fibrosis [2] . Approximately, 80% patients with ESRD have, at least, one form of heart disease [3] , and approximately, 40% have pulmonary hypertension based on echocardiographic parameters (elevated pulmonary artery systolic pressure (PASP)) [4] [5] [6] [7] .
Previous studies have suggested a relationship between the volume overload and elevated PASP [8] . Using continuous hemodynamic monitoring, one study described a decrease in right ventricular systolic pressure of 39% during dialysis, highlighting the important contribution of excess volume to right-sided pressures. In fact, a recently proposed classification system recognizes the potentially additive contribution of volume overload and structural heart disease to patients' functional status, and its authors highlight the need for studies to further elucidate the role of cardiac disease on function in the ESRD population [9] .
The widely utilized heart failure staging system, the New York Heart Association classification [10] , categorizes patients primarily according to their functional limitations during daily activities. Patients on chronic hemodialysis report extremely poor physical function [11, 12] . Perhaps because of the many possible causes of poor selfreported physical function in patients with ESRD, including uremic myopathy [13] , deconditioning from sedentary lifestyle [14] , anemia, comorbid conditions, and others, the contribution of cardiopulmonary abnormalities seems to have been underappreciated. Because elevated PASP is potentially a result of structural heart disease and volume overload in patients with ESRD, we hypothesized that a higher PASP would be associated with worse selfreported physical function in patients with ESRD.
We used data from the United States Renal Data System (USRDS) ACTIVE/ADIPOSE (A Cohort study To Investigate the Value of Exercise/Analyses Designed to Investigate the Paradox of Obesity and Survival in ESRD), which include echocardiogram reports, bioimpedance spectroscopy (BIS) measurements, and patient-reported physical function, to evaluate the association between elevated PASP and self-reported physical function in ESRD. In addition, we assessed the potential contributions of fluid overload and structural heart disease to a high PASP and poor physical function.
Methods
ACTIVE/ADIPOSE is a cohort study of the United States Renal Data System (USRDS) Nutrition and Rehabilitation/Quality of Life Special Studies Centers that enrolled prevalent hemodialysis patients from the Atlanta metropolitan area and the San Francisco Bay Area between July 2009 and August 2011. There were 771 patients who were enrolled and linked to USRDS. A description of the ACTIVE/ADIPOSE study and methods has been published elsewhere [15] . English-or Spanish-speaking patients who had been receiving dialysis for at least 3 months in 14 dialysis facilities in the San Francisco Bay Area and Atlanta metropolitan area were included. The study participants provided informed consent, and the study was approved by the Institutional Review Boards at Emory University and the University of California, San Francisco.
We performed a cross-sectional analysis to examine the association between PASP and self-reported physical function among 253 patients (33%) who had PASP recorded on reports from echocardiograms that were obtained as part of clinical care.
Clinical Echocardiogram Reports
We reviewed patient charts for clinical echocardiogram reports, and we selected the echocardiogram report with the date closest to the time of administration of the study questionnaire, if the patient had multiple echocardiogram reports. Each echocardiogram report was reviewed to abstract the left ventricular posterior wall thickness (LVPW), and estimated PASP. Left ventricular hypertrophy (LVH) is common in patients on hemodialysis and has been attributed to anemia, volume overload, heart failure, and hypertension [16] . LVH can cause cardiac stiffness leading to high left-sided filling pressures, which have been associated with elevated PASP [17, 18] . Left ventricular posterior wall thickness is a measure used to estimate LVH that has been associated with outcomes of a previous study of LVH in patients on hemodialysis [19] . We standardized the assumed right atrial pressure to 10 mm Hg, when calculating the PASP.
Physical Function Scale
The SF-36 is an instrument that uses 36 questions to assess health-related quality of life (HRQoL) that has previously been used in patients with ESRD [20, 21] . The Physical Function scale (PF) is a subscale of the SF-36 that uses ten items that are hierarchically ordered to assess physical function. Each item is scored based on the degree of physical limitation, and the total score is scaled to a 100-point total with higher scores indicating a better function [22] . The PF scale of the SF-36 was administered to patients before a mid-week or end-of-week dialysis session by a research assistant.
Bioimpedance Spectroscopy
We performed a whole-body BIS before a mid-week or end-ofweek dialysis session using a device that scans 256 frequencies between 4 and 1,000 kHz (SFB7; ImpediMed, San Diego, CA, USA), as previously described [23] . We placed electrodes on patients in a tetrapolar configuration on the hand and foot opposite the side of dialysis access after patients were supine for, at least, 10 min. The proximal and distal electrodes were placed 5 centimeters apart, and ten measurements were performed within 1 min. We estimated the total body water (TBW) by extrapolating resistance to infinite frequency and extracellular water (ECW) by extrapolating resistance to zero frequency.
Covariates
We included covariates based on a clinical conceptual model and included age, sex, African-American race, hemoglobin, diabetes mellitus, peripheral vascular disease, serum albumin, ESRD vintage (time since first ESRD treatment), heart failure, coronary 315 artery disease, and arteriovenous (AV) fistula hemodialysis access. We obtained data on coronary artery disease, heart failure, diabetes, and peripheral vascular disease from the Centers for Medicare and Medicaid Services (CMS) Medical Evidence Form 2728. We measured the serum albumin concentration with nephelometry. We used the most recent clinical hemoglobin level documented in the chart. Information about the use of an AV fistula was obtained from review of the hemodialysis prescription. These data were included because previous reports have linked an AV fistula creation with elevated pulmonary artery pressures [24] ; however, this association remains controversial [25] .
Statistical Analysis
We summarized data as mean (standard deviation) for normally distributed variables, median (25th, 75th percentile) for non-normally distributed variables, and proportions for dichotomous variables. We compared characteristics of patients with a PASP ≥ 35 mm Hg and those with a lower PASP using Chi-squared tests, t tests, and linear regression, as appropriate, because a PASP of ≥ 35 mm Hg has been used as a cutoff for pulmonary hypertension in previous studies in the ESRD population [4] [5] [6] . We examined the time between the echocardiogram and PF testing. We used multivariate linear regression with PASP as the primary predictor and the PF score as the primary outcome.
To determine whether associations between PASP and PF were driven by fluid overload or left ventricular hypertrophy, we first assessed whether PASP was associated with ECW and with left ventricular posterior wall thickness. We then added BIS results and left ventricular posterior wall thickness into a multivariable model separately and then jointly. We performed a sensitivity analysis excluding echocardiograms that were done more than 2 years from the time of PF testing. We conducted all analyses using Stata 13 (StataCorp LP).
Results
The mean age of the cohort was 55.8 years. Clinical characteristics did not differ significantly between patients with PASP ≥ 35 and those with a lower PASP ( table 1 ). The median interval between the PF test and echocardiogram was 19 days (302 days before PF testing, 407 days after PF testing). Patients included in the study were more likely to have a longer ESRD vintage and were less likely to have an AV fistula when compared to patients who were excluded (online suppl. table 1, www.karger.com/doi/10.1159/000431334).
Association between PASP and PF
In the univariate analysis, every 10 mm Hg higher PASP was associated with a 5.7-point lower PF score (95% CI -8.4, -2.9). In the multivariable model, each 10 mm Hg higher PASP was associated with 3.32-point lower PF score (95% CI -5.95, -0.68; table 2 ). Diabetes mellitus, older age, lower serum albumin concentration, and female sex were also associated with a significantly lower PF. 
Etiology of Elevated PASP

Sensitivity Analysis
We performed a sensitivity analysis, excluding participants with echocardiogram reports that were done more than two years from the completion of the SF-36 (n = 35 
Discussion
We demonstrated that higher pulmonary artery systolic pressures were associated with worse self-reported physical function after adjustment for age, sex, diabetes, peripheral vascular disease, serum albumin, and hemoglobin. Both left ventricular posterior wall thickness and ECW when adjusted for body size by including FM and intracellular water (ICW) were independently associated with a higher PASP. ECW was associated with a lower PF score, suggesting that the volume overload may be a detrimental factor in the physical function of patients on hemodialysis. Similarly, left ventricular posterior wall thickness was associated with a lower PF score in a multivariable model.
The causes of pulmonary hypertension in ESRD patients have been recently reviewed [4] , and the chronic volume overload is a likely contributor [26] . The linear association between BIS measures of volume overload, PASP, and the PF score highlights the importance of close monitoring of volume status in patients on hemodialysis and suggests that the volume overload could be one factor contributing to poor physical function in this population. Because the intravascular volume is influenced by ECW, we expected that ECW would be related to PASP. The potential adverse effect of volume overload on physical function was also highlighted by a recent study that showed lower PF scores in patients with asymptomatic pulmonary congestion [27] . Left ventricular hypertrophy is common in ESRD patients, with approximately 75% patients starting hemodialysis, meeting criteria for LVH [28] . The left ventricular posterior wall thickness is an echocardiographic measure of left ventricular hypertrophy, which leads to left ventricular stiffness and diastolic dysfunction [18] . The finding that the worse LVH was associated with lower PF score suggests that ventricular stiffness related to left ventricular hypertrophy is also potentially a contributor to poor selfreported physical function in patients on hemodialysis.
In a recently published proposed functional classification of heart failure in patients with ESRD, the three major mechanisms described to induce cardiomyopathy were volume overload, pressure overload, and nonhemodynamic factors, including the renin-angiotensin system activation [9] . This proposed classification from the Acute Dialysis Quality Initiative Workgroup uses echocardiogram abnormalities and dyspnea assessment before and after renal replacement therapy to classify the severity of heart failure. Our study draws attention to the relationships between self-reported functional status, volume overload, pulmonary artery systolic pressure, and left ventricular hypertrophy that underlie this proposed classification. KDOQI guidelines recommend performing echocardiograms at the initiation of hemodialysis and at regular intervals [29] , an approach that could direct clinicians to possible strategies, such as an additional ultrafiltration or treatment aimed at an underlying cardiac disease, to improve physical function.
For example, previous studies have evaluated strategies for managing LVH in ESRD. The authors of a metaanalysis of frequent or extended hemodialysis concluded that frequent or extended hemodialysis was associated with a significant reduction of left ventricular mass index and mean blood pressure and an improvement in the ejection fraction [30] . Similarly, a secondary analysis of the Frequent Hemodialysis Network (FHN) trial found that frequent in-center hemodialysis reduced left and right ventricular end systolic and diastolic ventricular volumes along with left ventricular mass [31] . Although these data support left ventricular hypertrophy being addressable with hemodialysis, we cannot be certain of the effect of reduced left ventricular mass on physical function until prospective studies are conducted.
To put our population in context, 51% of our cohort had a PASP of 35 mm Hg or higher, a proportion similar to previous cohorts of hemodialysis patients [5] [6] [7] . The mean PF score was 51.9, slightly higher than the mean PF score of 44 for multiple ESRD cohorts reported in a previous review [32] . Comparing our results to those of the FHN population, age and diabetes were similarly associated with lower PF scores, and higher albumin and male sex were associated with higher PF scores [33] . In contrast to findings from the FHN, peripheral vascular disease was not significantly associated with lower PF scores in our population.
The minimal clinically important difference (MCID) has been described as the 'smallest benefit of value to patients' [34] . Previous studies have determined the MCID for the SF-36 to be 3-5-points [35, 36] . Using this cutoff, both 5-mm higher left ventricular posterior wall thickness and 10-mm higher PASP were associated with clinically significant impairment of PF. Another way to put these results into context is to compare the association of age with PF. We found coefficients for higher PASP, ECW, and LVPW in our study that were comparable to the difference associated with 10 years of age [37] .
Strengths of our study included careful measurement of body composition and use of the PF, which allows for comparison with other populations. However, several limitations of our study should be addressed. First, only patients who had echocardiograms were included in the study, which might limit the generalizability of the findings. Second, echocardiograms in the study were obtained as part of a routine clinical practice rather than according to a standardized study protocol. As a result, the reporting of echocardiographic parameters was not uniform. In addition, the time between echocardiograms and BIS and PF measures was variable, and we do not know when echocardiograms were performed relative to hemodialysis procedures. These limitations would be expected to bias the results to the null (that is, to potentially obscure an association between echocardiographic parameters and physical function). Only patients with a clinical indication for an echocardiogram were included in the study, which could lead to spectrum bias, however, we used continuous predictors of PASP, ECW, and LVPW that were not categorized and found a linear association with the PF score. Third, we did not specifically ask patients about dyspnea on exertion, a major criterion in the NYHA classification, but we did ask if their health limited them in daily activities, and we believe that dyspnea would usually be reported as a health-related limitation. Fourth, we did not have longitudinal data on the use of angiotensin-converting enzyme (ACE) inhibitors or angiotensin receptor blockers (ARB) that could have influenced the relationship between the left ventricular mass and physical function.
In summary, higher PASP was associated with lower self-reported physical function in patients on hemodialysis. The role of chronic volume overload on PASP and PF
